Study finds weight loss results drive continued Ozempic use despite nausea and other side effects, based on real world ...

Natco Pharma shares climbed over 11% on February 16 after receiving approval to launch Semaglutide in India. Semaglutide is ...

By Tarun Sai Lomte Widely used weight-loss and diabetes drugs show clear benefits, but emerging evidence clarifies their side effects, rare risks, and what clinicians should monitor long term. Review: ...

Find out more about how tirzepatide performed better than semaglutide in weight reduction in a 2026 network meta-analysis.

By Dr. Priyom Bose, Ph.D. An examination of user reviews finds that people continue off-label Ozempic when it delivers ...

An AI-designed obesity drug targeting the GIP receptor shows over 31% weight loss in preclinical tests, raising hopes for next-generation metabolic treatments beyond GLP-1 drugs.

The study found that the perceived effectiveness of Ozempic for weight loss is the primary driver of patient satisfaction and intent to continue treatment, even when experiencing side effects.

Researchers have discovered that drugs like Ozempic for diabetes and obesity also improve alcohol use disorders and other ...

There is some laboratory evidence that select compounds from berberine, the polyphenols in green tea extract and ...

The recent withdrawal of Hims & Hers’ GLP-1 pill raises questions about the safety and effectiveness of compounded medications ...

Adults with obesity may now move directly from Wegovy 2.4mg to 7.2mg if they need greater weight loss ...

Novo Nordisk stock sinks 21% in a month as weak 2026 guidance, slowing semaglutide sales, and rising competition overshadow ...